Use of transfer factor for NO (TLNO)

H. Guenard (Bordeaux, France)

Source: Annual Congress 2013 –Will the combination of TLNO (transfer factor for nitric oxide) and TLCO be more useful in pulmonary function testing than TLCO alone?

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. Guenard (Bordeaux, France). Use of transfer factor for NO (TLNO). Annual Congress 2013 –Will the combination of TLNO (transfer factor for nitric oxide) and TLCO be more useful in pulmonary function testing than TLCO alone?

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
In defence of the carbon monoxide transfer coefficient KCO (TL/VA)
Source: Eur Respir J 2001; 17: 168-174
Year: 2001



Carbon monoxide transfer coefficient (transfer factor/alveolar volume) in females versus males.
Source: Eur Respir J 2003; 22: 570
Year: 2003


Can the intra-test variability of the single breath transfer factor of carbon monoxide method (TLCOsb) be improved to less than 5%?
Source: International Congress 2015 – Functional and imaging techniques for assessing lung, airway and respiratory muscles
Year: 2015

Carbon monoxide transfer coefficient (transfer factor/alveolar volume) in females versus males
Source: Eur Respir J 2003; 22: 186-187
Year: 2003


Association of the transfer coefficient (Kco) with emphysema progression in heavy smokers
Source: Annual Congress 2011 - Phenotyping and monitoring of airway diseases
Year: 2011


The use of predicted vs actual haemoglobin in the calculation of gas transfer (TLCO) in lung cancer pathways
Source: Virtual Congress 2020 – Localised non-small cell lung cancer
Year: 2020


Global Lung Function Initiative (GLI) - Statutes: Deriving global multi-ethnic reference values for the transfer factor of carbon monoxide (TL,CO) in the lungs
Source: Global Lung Function Initiative
Year: 2013

Global lung function initiative: Reference equations for the transfer factor for carbon monoxide (TLCO)
Source: International Congress 2016 – The best is yet to come in terms of lung function
Year: 2016


Vascular endothelial growth factor (VEGF) is a predictable marker for FEV1 progression in patients with Lymphangiolyomyomatosis (LAM).
Source: International Congress 2019 – Innovative approaches for management and treatment of rare diffuse parenchymal lung diseases
Year: 2019


Expression of transforming growth factor β (TGFβ) receptor, CD105, is declined in Th1 interstitial lung diseases (ILDs)
Source: Annual Congress 2011 - Bronchoalveolar lavage and biomarkers in diffuse parenchymal lung disease
Year: 2011


Gravity dependence of specific ventilation (SV), Hounsfield unit (ΔHU) and specific gas volume (ΔSVg) variations assessed by high resolution (HR) CT
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013

Transfer factor for carbon monoxide
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-36-7, page=127
Year: 2005

Effect of sample volume size on single-breath transfer factor for the lung
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011

Substituting methane to helium in measuring the single breath CO transfer factor
Source: Eur Respir J 2002; 20: Suppl. 38, 381s
Year: 2002

Regional distribution of ventilation (V) and perfusion (Q) lung scan with radioactive particle aerosol (RPA) by three inhaler systems
Source: Eur Respir J 2006; 28: Suppl. 50, 509s
Year: 2006

The TL,NO/TL,CO ratio in pulmonary function test interpretation
Source: Eur Respir J 2013; 41: 453-461
Year: 2013



Validation of nitric oxide transfer factor predicted equations.
Source: International Congress 2019 – Insights into physiological diagnostic services
Year: 2019


Tobacco smoking (TS) in home oxygen therapy (HOT). Preliminary data (*)
Source: Annual Congress 2013 –COPD and tobacco management
Year: 2013


Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD)
Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis
Year: 2012

How reliable is total lung capacity (TLC) measured during single breath (SB) diffusion capacity test (DLCO) comparing to plethysmography (PL) method in diabetic subjects with normal lung function?
Source: Annual Congress 2009 - Quality control in lung function and new developments
Year: 2009